Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: A multicenter, randomized, double-blind trial

Archives of Internal Medicine

Volumn 158, Issue 11, 1998, Pages 1213-1220

  Reiss, Theodore F ^a   Chervinsky, Paul ^b   Dockhorn, Robert J ^c   Shingo, Sumiko ^a   Seidenberg, Beth ^a   Edwards, Thomas B ^d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Department of Biostatistics Merck Research Laboratories ^*

^c Intl Med Technol Consultants Inc

^d ALBANY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PLACEBO;

ADOLESCENT; ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

EID: 0032496618     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.11.1213     Document Type: Article

References (31)

1. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med. 1992;326:862-866.
2. Global Initiative for Asthma. A six-part asthma management program. In: Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report. Bethesda. Md: National Heart. Lung, and Blood Institute, National Institutes of Health; 1995:70-117. Publication 95-3659.
3. Cochrane GM. Compliance in asthma. Eur Respir Rev. 1995;28:164-165.
4. 4 on the airways in asthma. N Engl J Med. 1983;308:436-439.
5. 4 and granulocytic infiltration into asthmatic airways. Lancet. 1992;341:989-990.
6. 4-receptor antagonist, in subjects with bronchial asthma. Am J Respir Crit Care Med. 1994;150:618-623.
7. Israel E, Cohn J, Dubé L, Drazen JM, for the Zileuton Clinical Trial Group. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. JAMA. 1996;275:931-936.
8. Reiss TF, Altman LC, Chervinsky P, et al. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma. J Allergy Clin Immunol. 1996;98:528-534.
9. Noonan MJ, Chervinsky P, Brandon M, et al. for the Montelukast Asthma Study Group. Montelukast, a potent cysteinyl leukotriene antagonist, causes dose related improvements in chronic asthma. Eur Respir J. In press.
10. 4-receptor antagonist. Can J Physiol Pharmacol. 1995;73:191-201.
11. De Lepeleire I, Reiss TF, Rochette F, et al. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma. Clin Pharmacol Ther. 1995;61:83-92.
12. Standardization of Spirometry, 1994 update: American Thoracic Society criteria. Am J Respir Crit Care Med. 1995;152:1107-1136.
13. Santanello NC, Barber BL, Reiss TF, et al. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J. 1997;10:646-651.
14. Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment of health-related quality of life in asthma. Thorax. 1992;47:76-83.
15. Raftery EB. Cardiovascular drug withdrawal syndromes. Drugs. 1984;28:371-374.
16. Adelroth E, Inman MD, Summers E, Pace D, Modi M, O'Byrne PM. Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4-receptor antagonist cinalukast. J Allergy Clin Immunol. 1997;99:210-215.
17. Rangno RE, Langlois S. Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol. Br J Clin Pharmacol. 1982;13:345S-351S.
18. Nattel S, Rangno RE, Van-Loon G. Mechanism of propranolol withdrawal phenomena. Circulation. 1979;59:1158-1164.
19. Wolfe BB, Harden TK, Molinoff PB. In vitro study of beta-adrenergic receptors. Ann Rev Pharmacol Toxicol. 1977;17:575-604.
20. Israel E, Rubin P, Kemp JP, et al. The effect of inhibition of 5-lipoxygenase by zileuton in mild to moderate asthma. Ann Intern Med. 1993;119:1059-1066.
21. Bateman ED, Aitchison JA, Summerton L, Harris A. The early onset of action of zafirlukast (ACCOLATE™) in patients with asthma. Am J Respir Crit Care Med. 1997;155:A663.
22. 1 in patients with asthma. Am J Respir Crit Care Med. 1997;155:A665.
23. Petty TL, Rollins DR, Christopher K, Good JT, Oakley R. Cromolyn sodium is effective in adult chronic asthmatics. Am Rev Respir Dis. 1989;139:694-701.
24. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics. 1993;92:64-77.
25. Juniper JF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol. 1994;47:81-87.
26. Barnes N. Efficacy and effectiveness in treatment of asthma. Eur Resp Rev. 1995;30:284-287.
27. Reiss TF, Sorkness CA, Stricker W, et al. Effects of montelukast (MK-0476), a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. Thorax. 1997;52:45-48.
28. Altman LC, Munk Z, Seltzer J, et al, for the Montelukast Asthma Study Group. A placebo controlled, dose ranging study of montelukast, a cysteinyl leukotriene receptor antagonist. J Allergy Clin Immunol. In press.
29. Dworski R, Fitzgerald GA, Oates JA, et al. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med. 1994;149:953-959.
30. Paul WE, Metcalfe DD, Busse W, Reece ER; Goldstein RA, moderator. Asthma. Ann Intern Med. 1994;121:698-708.
31. Wickrmasinghe RG, Khan MA, Hoffbrand AV. Do leukotrienes play a role in the regulation of proliferation of normal and leukemic hemapoietic cells? Prostaglandins Leukot Essent Fatty Acids. 1993;48:123-126.